InnovAge Holding Corp.
NASDAQ:INNVMedical - Care Facilities
-$0.01 today
- Market cap
- $1.22B
- Beta
- 0.45
- P/E (TTM)
- -55.8
- EPS (TTM)
- -$0.16
Volume 0.52M
Average 0.29M
INNV Other Working Capital
Cash effect of changes in other operating assets and liabilities.
InnovAge Holding Corp.NASDAQ: INNV
Other Working Capital · Q3 FY2026 · quarter ended Mar 2026
Other working capital turns negative
Q3 FY2026 other working capital was -$1.42M, compared with $3.12M a year earlier. Trailing-twelve-month other working capital was -$16.61M.
Context
- Other working capital amounted to 1.9% of revenue in FY2025, down 1.1 pp from a year earlier.
- Other working capital increased in 1 of the last 3 fiscal years.
What to watch
Whether quarterly other working capital holds near -$1.42M or moves back toward the trailing-twelve-month quarterly average of -$4.15M.
Sources:Cash FlowText generated from reported figures; not investment advice.
Other Working Capital history
USD · from the cash flow
- Latest · FY2025
- (16.42M) USD
- Year-over-year change
- +29.2%
| Period | Period end | Other Working Capital | YoY change |
|---|---|---|---|
| FY2025 | 2025-06-30 | (16.42M) | +29.2% |
| FY2024 | 2024-06-30 | (23.18M) | -15.2% |
| FY2023 | 2023-06-30 | (20.12M) | -1054.5% |
| FY2022 | 2022-06-30 | 2.11M | +124.9% |
| FY2021 | 2021-06-30 | (8.47M) | — |
Other Working Capital vs competitors
How INNV compares with its peers on the latest reported figures
- INNV's LTM Mar 2026 other working capital of $16.61M is the 5th largest of the 8 companies compared; the peer median is $19.53M.
- Its year-over-year change of +272.1% is the 4th highest of 8, against a peer median of +252.3%.
- Other working capital amounts to 1.8% of revenue for INNV, versus a peer median of 1.9%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $122.56M | +634.8% | +76.3% | 2.2% | |
| LTM Jun 2026 | $30.47M | +252.3% | -34.3% | 2.1% | |
| LTM Sep 2026 | $28.08M | -17.0% | — | 1.8% | |
| LTM Mar 2026 | $19.53M | +339.5% | — | 1.9% | |
| LTM Mar 2026 | $16.61M | +272.1% | — | 1.8% | |
| LTM Sep 2026 | $16.6M | +292.4% | — | 0.6% | |
| LTM Mar 2026 | $9.29M | -343.6% | +41.6% | 2.3% | |
| LTM Oct 2026 | $7.63M | +130.4% | -22.7% | 0.3% | |
| Peer median (excluding INNV) | $19.53M | +252.3% | +9.5% | 1.9% | |
Competitors are the stored peer set for INNV. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Jun 2021 | FY2022 Jun 2022 | FY2023 Jun 2023 | FY2024 Jun 2024 | FY2025 Jun 2025 |
|---|---|---|---|---|---|
| Net Income | (43.99M) | (6.52M) | (23.22M) | (23.22M) | (35.34M) |
| Depreciation & Amortization | 13.35M | 14.35M | 18.95M | 18.95M | 19.51M |
| Deferred Income Tax | 0 | 0 | 1.22M | 1.22M | 1.3M |
| Stock-Based Compensation | 47.05M | 3.74M | 6.83M | 6.83M | 7.62M |
| Change in Working Capital | (2.59M) | (7.4M) | (52.15M) | (52.15M) | 15.24M |
| Accounts Receivables | 5.88M | (9.51M) | (33.4M) | (30.33M) | 11.22M |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 0 | 0 | 1.37M | 1.37M | 20.43M |
| Other Working Capital | (8.47M) | 2.11M | (20.12M) | (23.18M) | (16.42M) |
| Other Non-Cash Items | (21.37M) | 23.13M | 11.46M | 11.46M | 24.54M |
| Operating Cash Flow | (7.55M) | 27.3M | (36.9M) | (36.9M) | 32.87M |
| Capital Expenditures | (17.54M) | (38.24M) | (7.91M) | (7.91M) | (6.26M) |
| Acquisitions (Net) | 0 | 0 | (19.07M) | (19.07M) | (3.52M) |
| Purchases of Investments | 0 | 0 | (2.39M) | (2.39M) | (2.07M) |
| Sales of Investments | 0 | 0 | 3M | 3M | 6.3M |
| Other Investing Activities | (2M) | (2M) | 0 | 0 | 0 |
| Investing Cash Flow | (19.54M) | (40.24M) | (26.37M) | (26.37M) | (5.55M) |
| Debt Repayment | (139.45M) | (6.32M) | (8.43M) | (8.43M) | (9.91M) |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | (77.6M) | 0 | (179K) | (179K) | (7.32M) |
| Dividends Paid | (9.5M) | 0 | 0 | 0 | 0 |
| Other Financing Activities | 342.78M | 0 | 1.58M | 1.58M | (1.86M) |
| Financing Cash Flow | 116.22M | (6.32M) | (7.03M) | (7.03M) | (19.08M) |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 89.14M | (19.25M) | (70.31M) | (70.31M) | 8.23M |
| Free Cash Flow | (25.09M) | (10.94M) | (44.81M) | (44.81M) | 26.6M |
InnovAge Holding Corp.
NASDAQ:INNV
Intrinsic Alpha fair value
Locked
Current Price
$8.91
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.